August 2023

Customer Notification: Change in Screening assay for Mumps IgM and Measles IgM antibodies


The NVRL is pleased to notify users that following a successful verification Liaison™ Measles IgM and Liaison™ Mumps IgM assays are to be introduced as screening assays for blood samples from Monday 4th September 2023.

The current Microimmune™ assays for these infection markers will no longer be in use.


The wording on NVRL reports after this date will reflect this change.


Any queries in relation to this notification should be addressed to the Clinical Team on 01-7164401.




Posted By Helen.Dawkins read more

Customer Notification: Serodia T pallidum TPPA test is no longer available - replacement TPHA test is being introduced


NVRL has been notified that the Serodia TPPA Treponema pallidum Particle Agglutination assay is no longer available.

NVRL is delighted to inform its users that an alternative assay has been identified, the NewBio TPHA Treponema pallidum Haemagglutination assay, and following a
successful verification is to be introduced as of Monday 28th August 2023.

The NVRL User Manual will be updated in due course to reflect this change.

Posted By Helen.Dawkins read more